Flibanserin is used in clinical or research settings to help or improve the complex problem of female sexual dysfunction or hypoactive sexual desire disorder (HSDD) in premenopausal women.
Flibanserin is available now at Ultra Peptides. Check out our similar product PT 141. Click here!
Firstly, the research chemical Flibanserin (aka Addyi) is a psychotropic medication. It can potentially treat or improve the complex problem of female sexual dysfunction or hypoactive sexual desire disorder (HSDD) in premenopausal women.
The mechanism of action HSDD is not known. It may work by restoring prefrontal cortex control over the brain’s motivation/rewards structures, enabling sexual desire to manifest. This may occur by increasing dopamine and norepinephrine while transiently decreasing serotonin in the brain’s prefrontal cortex.
How Flibanserin works:
Secondly, Flibanserin is an orally bioavailable, non-hormonal, multifunctional serotonin agonist and antagonist (MSAA). To clarify, Flibanserin selectively binds to serotonin receptors in the central nervous system, acting as an agonist on 5-HT1A receptors and an antagonist on 5-HT2A receptors.
For example, Agonist activity at 5-HT1A postsynaptic receptors may enhance the release of dopamine and other monoamines. Combined with 5-HT2A antagonism, Flibanserin boosts levels of dopamine in the mesocortical area of the prefrontal cortex. Therefore, it produces a net increase of norepinephrine selectively in the prefrontal cortex through disinhibition of locus coeruleus noradrenergic neurons.
In addition, Flibanserin reduces concentrations of serotonin in the prefrontal cortex with chronic administration. Reducing serotonin, which modulates sexual activity in an inhibitory fashion through downstream decreases in dopamine release, while enhancing the release of norepinephrine and dopamine in the prefrontal cortex may improve sexual desire and interest.
Possible Benefits:
treat women with hypoactive sexual desire disorder (HSDD; a low sexual desire that causes distress or interpersonal difficulty) who have not experienced menopause (change of life; the end of monthly menstrual periods).
This designation allows the use of research chemicals and peptides strictly for in vitro testing and research, in laboratory settings only. Bodily introduction or injection of any kind, into humans or animals, is strictly illegal by law. This product is NOT for human use and can be harmful if ingested. This product is not in a sterile solution. It is not a drug, food, or cosmetic.
Flibanserin 50mg
$47.99
26,893.04 USD/BTC
0.056 USD/DOGE
49.31 USD/LTC
Flibanserin is used in clinical or research settings to help or improve the complex problem of female sexual dysfunction or hypoactive sexual desire disorder (HSDD) in premenopausal women.
Flibanserin is available now at Ultra Peptides. Check out our similar product PT 141. Click here!
Description
Flibanserin 50mg per ml x 30ml
Firstly, the research chemical Flibanserin (aka Addyi) is a psychotropic medication. It can potentially treat or improve the complex problem of female sexual dysfunction or hypoactive sexual desire disorder (HSDD) in premenopausal women.
The mechanism of action HSDD is not known. It may work by restoring prefrontal cortex control over the brain’s motivation/rewards structures, enabling sexual desire to manifest. This may occur by increasing dopamine and norepinephrine while transiently decreasing serotonin in the brain’s prefrontal cortex.
How Flibanserin works:
Secondly, Flibanserin is an orally bioavailable, non-hormonal, multifunctional serotonin agonist and antagonist (MSAA). To clarify, Flibanserin selectively binds to serotonin receptors in the central nervous system, acting as an agonist on 5-HT1A receptors and an antagonist on 5-HT2A receptors.
For example, Agonist activity at 5-HT1A postsynaptic receptors may enhance the release of dopamine and other monoamines. Combined with 5-HT2A antagonism, Flibanserin boosts levels of dopamine in the mesocortical area of the prefrontal cortex. Therefore, it produces a net increase of norepinephrine selectively in the prefrontal cortex through disinhibition of locus coeruleus noradrenergic neurons.
In addition, Flibanserin reduces concentrations of serotonin in the prefrontal cortex with chronic administration. Reducing serotonin, which modulates sexual activity in an inhibitory fashion through downstream decreases in dopamine release, while enhancing the release of norepinephrine and dopamine in the prefrontal cortex may improve sexual desire and interest.
Possible Benefits:
Molecular Formula: C20H21F3N4O
Molecular Mass: 390.410 g/mol -1
Amino sequence: 1-[2-(1,3-dihydro-2-oxobenzimidazol-1-yl)
THIS PRODUCT IS FOR RESEARCH ONLY
This designation allows the use of research chemicals and peptides strictly for in vitro testing and research, in laboratory settings only. Bodily introduction or injection of any kind, into humans or animals, is strictly illegal by law. This product is NOT for human use and can be harmful if ingested. This product is not in a sterile solution. It is not a drug, food, or cosmetic.
Please read our Terms and Conditions prior to ordering.
Additional information
Liquid
50mg/mL
30mL
Transparent
Ultra Peptides
You may also like…
PT 141 10mg
$34.99 Add to cartRelated products
Exemestane 25mg
$42.99 Add to cartAdrafinil 150mg
$33.99 Read moreGW1516 10mg
$44.99 Add to cartClenbuterol 200mcg
$24.99 Add to cart